Groupe Berkem Reports its 2022 Full-Year Results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Groupe Berkem Postpones the Publication of Its 2022 Annual Results and Its 2022 Annual Report, Due to the Transition to IFRS streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Strategic acquisitions of i.Bioceuticals in the US and Biopress in France: - Strengthening the Group's solutions for its many markets - Expansion of the offer in the nutraceutical and agri-food
27.04.2023 - Regulatory News: Groupe Berkem (Paris:ALKEM), a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), announces the postponement the publication of its annual results for the year ending December 31, 2022. Initially .